Practical utilization of sonography for the assessment of muscle diseases in rheumatology DOI
Takeshi Yoshida, Jemima Albayda

Best Practice & Research Clinical Rheumatology, Journal Year: 2025, Volume and Issue: unknown, P. 102055 - 102055

Published: March 1, 2025

Language: Английский

Association of systemic inflammatory response index with bone mineral density, osteoporosis, and future fracture risk in elderly hypertensive patients DOI

Huimin Ma,

Xintian Cai, Junli Hu

et al.

Postgraduate Medicine, Journal Year: 2024, Volume and Issue: 136(4), P. 406 - 416

Published: May 16, 2024

This study sought to investigate the relationship between systemic inflammatory response index (SIRI) and bone mineral density (BMD), osteoporosis, future fracture risk in elderly hypertensive patients.

Language: Английский

Citations

27

Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective DOI Open Access
Changyong Li,

Da-Gui Zhang,

Yu-Jing Pan

et al.

Polymers, Journal Year: 2023, Volume and Issue: 15(16), P. 3354 - 3354

Published: Aug. 10, 2023

With the success of several clinical trials products based on human serum albumin (HSA) and rapid development nanotechnology, HSA-based nanodrug delivery systems (HBNDSs) have received extensive attention in field nanomedicine. However, there is still a lack comprehensive reviews exploring broader scope HBNDSs biomedical applications beyond cancer therapy. To address this gap, review takes systematic approach. Firstly, it focuses crystal structure potential binding sites HSA. Additionally, provides summary recent progresses for various over past five years, categorized according to type therapeutic drugs loaded onto These categories include small-molecule drugs, inorganic materials bioactive ingredients. Finally, summarizes characteristics current application status drug delivery, also discusses challenges that need be addressed transformation HSA formulations offers future perspectives field.

Language: Английский

Citations

29

Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases DOI
Frank Buttgereit, Andriko Palmowski, Milena Bond

et al.

Nature Reviews Rheumatology, Journal Year: 2024, Volume and Issue: 20(7), P. 417 - 431

Published: June 3, 2024

Language: Английский

Citations

13

Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies DOI

Youle Zheng,

Feng Jin,

Yixin Yu

et al.

Archives of Pharmacal Research, Journal Year: 2024, Volume and Issue: 47(4), P. 301 - 324

Published: April 1, 2024

Language: Английский

Citations

12

Inflammatory macrophage reprogramming strategy of fucoidan microneedles-mediated ROS-responsive polymers for rheumatoid arthritis DOI
Xiaowei Liu,

Ningning Diao,

Shiqing Song

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 271, P. 132442 - 132442

Published: May 16, 2024

Language: Английский

Citations

9

Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study DOI
Sho Fukui, Wolfgang C. Winkelmayer­, Sara K. Tedeschi

et al.

Annals of the Rheumatic Diseases, Journal Year: 2024, Volume and Issue: 84(2), P. 201 - 209

Published: Aug. 26, 2024

Introduction

Chronic kidney disease (CKD) is a common comorbidity of rheumatoid arthritis (RA). The association longitudinal RA activity with long-term function has remained uncertain.

Method

We analysed multicentre prospective registry in the USA from 2001 to 2022. exposure was updated time-averaged Clinical Disease Activity Index (TA-CDAI) categories study enrolment. primary outcome estimated glomerular filtration rate (eGFR) change. Secondary outcomes included developments CKD stage G3a (eGFR<60 mL/min/1.73 m2) and G3b (eGFR<45 m2). Results were adjusted for relevant time-fixed time-varying covariates.

Results

31 129 patients (median age: 58.0 years, female: 76.3%, median eGFR: 90.7 contributed 234 973 visits 146 778 person-years follow-up. Multivariable mixed-effect linear model showed an average annual eGFR decline during follow-up TA-CDAI-remission group −0.83 m2 additional declines (95% CI) –0.09 (–0.15 –0.03) low, –0.17 (−0.23 –0.10) moderate −0.18 (–0.27 –0.08) high patients. Compared TA-CDAI remission, HRs 1.15 (1.01 1.30) 1.22 (1.06 1.40) 1.27 (1.05 1.52) activity; G3b, (0.84 1.76) 1.66 (1.12 2.45) 1.93 (1.16 3.20) activity.

Conclusions

Higher associated accelerated increased risk clinically dysfunction. Future intervention studies should attempt replicate between eGFR.

Language: Английский

Citations

8

Relationship between physical function and sarcopenia in the older adults from Amazonas: A cross-sectional study DOI Creative Commons
Alex Barreto de Lima, Duarte Henriques‐Neto, David Scott

et al.

PLoS ONE, Journal Year: 2025, Volume and Issue: 20(3), P. e0320079 - e0320079

Published: March 19, 2025

Physical functioning refers to the ability perform daily living activities, namely basic instrumental, and advanced activities. Poorer performance in these areas may indicate potential presence of sarcopenia. To analyze differences physical function between older people with without sarcopenia investigate associations tests A cross-sectional study based on data from Northern region Brazil year 2018 was conducted. Study participants included 312 aged ≥ 60 years (64.1% female). Sarcopenia defined using updated criteria European Working Group Older People (EWGSOP2). measured functional fitness (30-second chair stand test, sit-and-reach 8-foot Up-and-Go Test, 6-minute walk 4-meter gait speed, Fullerton Advanced Balance Scale). Confirmed detected 29.2% participants, but no participant had severe Most parameters crude analysis were associated confirmed (all p < 0.05), except for back scratch test. In a model adjusted sex, age body mass index, slower speed (OR = 1.29, 95%CI 1.08 1.54), up-and-go test time 1.32, 1.16 1.49), greater 0.97, 0.94 0.99) higher self-reported Composite Function scores 0.94, 0.89 significantly status. EWGSOP2 is prevalent residing Brazil's independently walking rising ability, reduced trunk lower-limb flexibility, as well poorer function.

Language: Английский

Citations

1

The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches DOI
Nikhil Gupta, Navjot Kanwar, Anchal Arora

et al.

Clinical Rheumatology, Journal Year: 2024, Volume and Issue: 43(5), P. 1421 - 1433

Published: March 18, 2024

Language: Английский

Citations

7

Non-Pharmacological Strategies for Managing Sarcopenia in Chronic Diseases DOI Creative Commons
Jiawen Hu, Yiwen Wang, Xiaojian Ji

et al.

Clinical Interventions in Aging, Journal Year: 2024, Volume and Issue: Volume 19, P. 827 - 841

Published: May 1, 2024

Abstract: This article focuses on a range of non-pharmacological strategies for managing sarcopenia in chronic diseases, including exercise, dietary supplements, traditional Chinese intestinal microecology, and rehabilitation therapies individuals with limited limb movement. By analyzing multiple studies, the aims to summarize available evidence manage diseases. The results strongly emphasize role resistance training addressing diseases secondary sarcopenia. Maintaining appropriate frequency intensity can help prevent muscle atrophy effectively reduce inflammation. Although aerobic exercise has ability improve skeletal mass, it does have some positive effects physical function. Building upon this, explores potential benefits combined approaches, highlighting their helpfulness overall quality life. Additionally, also highlights importance supplements combating It protein intake, rich essential amino acids omega-3, as well sufficient vitamin D atrophy. Combining appears be an effective strategy preventing sarcopenia, although optimal dosage type supplement remain unclear. Furthermore, microecology Probiotics, prebiotics, bacterial products are suggested new treatment options emerging such whole body vibration training, blood flow restriction, electrical stimulation show promise treating Overall, this provides valuable insights into emphasizes holistic integrated approach that incorporates nutrition, multidisciplinary interventions, which promote health elderly population. Future research should prioritize high-quality randomized controlled trials utilize wearable devices, smartphone applications, other advanced surveillance methods investigate most intervention associated different Keywords: disease, inflammation

Language: Английский

Citations

7

Prevalence and risk factors of sarcopenia in patients on maintenance hemodialysis: a retrospective cohort study DOI Creative Commons

Qianyun Zhao,

Yuyu Zhu,

Xin Zhao

et al.

BMC Musculoskeletal Disorders, Journal Year: 2024, Volume and Issue: 25(1)

Published: May 31, 2024

Abstract Background This study aimed to explore the prevalence and related risk factors of sarcopenia in patients on maintenance hemodialysis (MHD). Methods cohort enrolled 165 MHD. The were divided into non-sarcopenia groups based presence or not. Sarcopenia was diagnosed according consensus Asian Working Group that considers reduced muscle mass decreased strength (19). measured using multi-frequency bioelectrical impedance (Inbody260) skeletal index (SMI) used: <7.0 kg/m 2 (male); <5.7 (female) - with reduction. electronic grip dynamometer used for measuring dominant handgrip (HGS) reflect strength. Male HGS < 28 kg female 18 considered a decrease demographic characteristics, laboratory indexes, anthropometrical measurements, body compositions, InBody score compared between groups. multivariate logistic regression sarcopenia. Results Of MHD, 36 had sarcopenia, 21.82%. Patients group higher ages lower index, serum albumin level, circumference waist, hip, biceps, strength, total water content, protein inorganic salt concentrations, mass, basal metabolic rate, obesity degree, SMI, fat content. showed age, waist circumference, influencing hemodialysis. Conclusion high Higher independent such patients.

Language: Английский

Citations

7